Free Trial

Zomedica (ZOMDF) Short Interest Ratio & Short Volume

Zomedica logo
$0.06 +0.00 (+4.17%)
As of 03:55 PM Eastern

Zomedica Short Interest Data

Zomedica (ZOMDF) has a short interest of 132,100 shares. This marks a -25.24% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 3.67 million shares to cover all short positions.

Current Short Interest
132,100 shares
Previous Short Interest
176,700 shares
Change Vs. Previous Month
-25.24%
Dollar Volume Sold Short
$10.42 thousand
Short Interest Ratio
0.0 Days to Cover
Last Record Date
September 30, 2025
Outstanding Shares
979,950,000 shares
Percentage of Shares Shorted
0.01%
Today's Trading Volume
732,364 shares
Average Trading Volume
3,669,187 shares
Today's Volume Vs. Average
20%
Short Selling Zomedica?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Zomedica and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

ZOMDF Short Interest Over Time

ZOMDF Days to Cover Over Time

ZOMDF Percentage of Float Shorted Over Time

Zomedica Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/2025132,100 shares $10.42 thousand -25.2%N/A0 $0.08
9/15/2025176,700 shares $15.04 thousand -34.0%N/A0 $0.09
8/31/2025267,700 shares $11.70 thousand -16.3%0.0%0.2 $0.04
8/15/2025319,900 shares $12.83 thousand -14.7%N/A0.1 $0.04
7/31/2025375,000 shares $15 thousand -16.0%0.0%0.2 $0.04
7/15/2025446,400 shares $16.96 thousand -37.5%N/A0.2 $0.04
6/30/2025714,200 shares $28.93 thousand +31.8%0.1%0.3 $0.04
6/15/2025541,700 shares $25.03 thousand -18.2%0.1%0.3 $0.05
5/31/2025662,300 shares $31.79 thousand -8.3%0.1%0.2 $0.05
5/15/2025722,200 shares $42.61 thousand -10.8%N/A0.3 $0.06
4/30/2025809,200 shares $45.56 thousand -13.7%N/A0.3 $0.06
4/15/2025937,400 shares $46.96 thousand -36.0%N/A0.3 $0.05
3/14/20252,271,100 shares $0.00 No ChangeN/A0.1 $0.00

ZOMDF Short Interest - Frequently Asked Questions

What is Zomedica's current short interest?

Short interest is the volume of Zomedica shares that have been sold short but have not yet been covered or closed out. As of September 30th, investors have sold 132,100 shares of ZOMDF short. Learn More on Zomedica's current short interest.

Is Zomedica's short interest increasing or decreasing?

Zomedica saw a decline in short interest in the month of September. As of September 30th, there was short interest totaling 132,100 shares, a decline of 25.2% from the previous total of 176,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Zomedica's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Zomedica: Immuneering Corporation (17.35%), Tiziana Life Sciences Ltd (2.03%), Cartesian Therapeutics, Inc. (26.57%), Lifecore Biomedical, Inc. (7.84%), Lunai Bioworks Inc. (0.82%), Foghorn Therapeutics Inc. (3.28%), Heron Therapeutics, Inc. (18.76%), ProQR Therapeutics N.V. (1.10%), Sagimet Biosciences Inc. (10.45%), Enanta Pharmaceuticals, Inc. (15.67%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($15.71 billion), Robinhood Markets, Inc. ($7.56 billion), Reddit Inc. ($4.55 billion), Coinbase Global, Inc. ($4.53 billion), CoreWeave Inc. ($4.43 billion), Charter Communications, Inc. ($4.07 billion), Seagate Technology Holdings PLC ($3.94 billion), IonQ, Inc. ($3.78 billion), TC Energy Corporation ($3.13 billion), and Live Nation Entertainment, Inc. ($3.12 billion). View all of the most shorted stocks.

What does it mean to sell short Zomedica stock?

Short selling ZOMDF is an investing strategy that aims to generate trading profit from Zomedica as its price is falling. ZOMDF shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Zomedica?

A short squeeze for Zomedica occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ZOMDF, which in turn drives the price of the stock up even further.

How often is Zomedica's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZOMDF, twice per month. The most recent reporting period available is September, 30 2025.




This page (OTC:ZOMDF) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners